Recombinant SARS-Cov-2 Spike protein(BA.2.86), (HEK293)
Applications
Reactivity
| Overview | |
| Catalog # | bs-43192P-100ug |
| Product Name | Recombinant SARS-Cov-2 Spike protein(BA.2.86), (HEK293) |
| Applications | Others |
| Reactivity | Others |
| Specifications | |
| Conjugation | Unconjugated |
| Source | Recombinant SARS-Cov-2 Spike protein(BA.2.86) is expressed in HEK293 cell with C-T4 foldon domain&His. It contains the amino acid sequence of 16-1213/1273 |
| Storage Buffer | 0.01M TBS(pH7.4) |
| Storage Condition | The product should be stored at -70°C or -20°C. |
| Target | |
| Gene ID | 43740568 |
| Swiss Prot | P0DTC2 |
| Background | The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. |
Powered by Bioz